Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence

Marine Gross-Goupil; Lubomir Bodnar; Matthew T. Campbell; Agnieszka Michael; Balaji Venugopal; Jakub Żołnierek; Pascale Dutailly; Giuseppe Procopio; Laurence Albiges

doi:10.1016/j.clgc.2023.11.001

Back

Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence

Journal article

Peer reviewed

Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence

Marine Gross-Goupil, Lubomir Bodnar, Matthew T. Campbell, Agnieszka Michael, Balaji Venugopal, Jakub Żołnierek, Pascale Dutailly, Giuseppe Procopio and Laurence Albiges

Clinical genitourinary cancer

11/2023

DOI: https://doi.org/10.1016/j.clgc.2023.11.001

Metrics

6 Record Views

Details

Title: Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence
Creators: Marine Gross-Goupil
Lubomir Bodnar
Matthew T. Campbell
Agnieszka Michael - University of Surrey
Balaji Venugopal
Jakub Żołnierek
Pascale Dutailly
Giuseppe Procopio
Laurence Albiges
Publication Details: Clinical genitourinary cancer
Date published: 11/2023
Identifiers: 99831661802346
Academic Unit: School of Biosciences
Language: English
Resource Type: Journal article
SDG (Scopus 2023): SDG 3

Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence

Metrics

Details

Usage Policy